Friday, July 11, 2014





Pfizer to pay $491M to resolve drug marketing case


July 30. 2013 4:14PM
Associated Press

Story Tools
PrintPrint | E-MailEMail | SaveSave | Hear Generate QR Code QR
Send to Kindle


(AP) Pfizer and the Justice Department say the drugmaker will pay almost $491 million to resolve an investigation into illegal marketing of the company's organ transplant drug Rapamune.


Rapamune was approved in 1999 for use in kidney transplant patients, and the Justice Department says sales representatives were trained to market the drug for use in other patients.


The U.S. Department of Justice says Pfizer Inc. will pay $257.4 million in civil settlements with federal and state governments and a $157.6 million criminal fine. It will also forfeit $76 million in assets.


Rapamune was originally made by Wyeth. Pfizer bought Wyeth in 2009.


The parties announced a proposed $491 million settlement in October.


Associated Press


Comments
comments powered by Disqus Commenting Guidelines
Poll
Mortgage Minute


Search for New & Used Cars

Make 
Model
 
Used New All
 

Search Times Leader Classifieds to find just the home you want!

Search Times Leader Classifieds to find just what you need!

Search Pet Classifieds
Dogs Cats Other Animals



Social Media/RSS
Times Leader on Twitter
Times Leader on Youtube
Times Leader on Google+
The Times Leader on Tumblr
The Times Leader on Pinterest
Times Leader RSS Feeds